Clen – Clenbuterol 40 mcg
Clen is presented in the ORYVION catalog as a tablet formulation containing 40 mcg of clenbuterol per tablet, supplied in containers of 100 tablets. Clenbuterol is a long-acting beta-2 adrenergic receptor agonist with bronchodilator activity.
Its mechanism of action involves stimulation of beta-2 receptors, promoting relaxation of airway smooth muscle. It has been used medically for certain respiratory conditions in some countries. Its adrenergic effects also influence cardiovascular function and metabolism; these effects do not establish safe or effective use for weight loss or athletic performance.
Product Specifications:
Commercial name: Clen
Listed compound: Clenbuterol
Declared strength: 40 mcg per tablet
Format: Tablets
Package contents: 100 tablets
Important Note:
Clenbuterol can cause rapid heart rate, palpitations, tremors, anxiety, low blood potassium, and elevated blood glucose. Serious toxicity can include abnormal heart rhythms, heart attack, and cardiac arrest. Its prolonged effects can cause symptoms to persist for several days.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.